President Kathryn Miranda, PhD, Department of Pathology, Microbiology and Immunology, School of Medicine
Dr. Kathryn Miranda is an immunologist who studies the immunomodulatory effects of cannabinoids in inflammatory and autoimmune diseases. She earned her Ph.D. in Biomedical Science from the University of South Carolina under the mentorship of Drs. Mitzi and Prakash Nagarkatti. Her dissertation focused on the roles of epigenetics and microbiota in endocannabinoid-mediated regulation of inflammation during high-fat diet-induced obesity; and was supported by a SPARC graduate research grant from the Office of the Vice President for Research. Dr. Miranda has received scientific achievement awards from professional societies to which she holds active membership including the American Association of Immunologists, Society of Toxicology, and International Cannabinoid Research Society. She currently serves as Postdoctoral Representative for the Mechanisms Specialty Section of the Society of Toxicology. Her postdoctoral research at the UofSC School of Medicine is aimed at elucidating anti-inflammatory mechanisms of phytocannabinoids, such as Cannabidiol, in macrophage-driven inflammatory disorders. She is excited to promote advancement of the UofSC PDA by supporting ongoing initiatives and officially representing the association before university leadership.